Allakos’s $134 Million Initial Public Offering

Wilson Sonsini Goodrich & Rosati represented Allakos in the offering Allakos, a clinical-stage biotechnology company focused on the development of antibodies for the treatment of various…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here